Cross-cultural and clinical validation of the MDHAQ/RAPID3 questionnaire in electronic format for a Brazilian population of patients with rheumatoid arthritis.
Ilka Benedet LineburgerClaiton Viegas BrenolAlice Silveira GoularteEdila Penna PinheiroVânia Naomi HirakataPublished in: Advances in rheumatology (London, England) (2022)
The use of MDHAQ/RAPID3 associated with traditional clinical measures can adequately allow for remote follow-up based on the 'treat-to-target' approach with performance comparable to the gold standard DAS28, being a viable tool in the sample of Brazilian patients with RA in the current context of telehealth.